DiMarco J P, Lerman B B, Kron I L, Sellers T D
J Am Coll Cardiol. 1985 Oct;6(4):759-68. doi: 10.1016/s0735-1097(85)80479-4.
Sustained ventricular tachycardia or fibrillation that develops during the early recovery period after acute myocardial infarction is a common clinical problem whose management remains controversial. Fifty-three patients who survived an initial episode of sustained ventricular tachycardia or fibrillation occurring between 3 and 60 days (mean +/- SD 21 +/- 16) after myocardial infarction were evaluated. Most of these patients had had a large (peak creatine kinase = 1,729 +/- 882 IU) complicated infarction. Forty-two (79%) of the 53 patients had had repetitive sustained ventricular arrhythmias and the condition of 19 of these could not be stabilized with drug therapy. Twenty-eight patients received medical therapy only. Twenty-four survived and were discharged from the hospital. Twenty-five patients underwent infarctectomy or aneurysmectomy either on an emergency basis (16 patients) or electively because of coexistent heart failure or angina (9 patients). Intraoperative mapping was attempted in these patients but was completely successful in only 13 (52%). Operative mortality was 16% with all deaths occurring in patients who were in shock before surgery. Five of 21 surgically treated survivors required long-term antiarrhythmic therapy. Twenty-one of 24 patients medically treated remain alive and well after 15 +/- 10 months of follow-up. Nineteen of 21 surgically treated patients remain alive and well after 17.9 +/- 11 months. One of these patients required reoperation for severe mitral regurgitation. These results confirm the poor medical prognosis of sustained ventricular tachyarrhythmias that present during the first 2 months after myocardial infarction but demonstrate that an acceptable rate of survival can be achieved with a combined medical and surgical approach to therapy.
急性心肌梗死后早期恢复阶段出现的持续性室性心动过速或颤动是一个常见的临床问题,其治疗仍存在争议。对53例在心肌梗死后3至60天(平均±标准差21±16天)发生首次持续性室性心动过速或颤动且存活下来的患者进行了评估。这些患者大多数发生了大面积(峰值肌酸激酶=1729±882 IU)的复杂性梗死。53例患者中有42例(79%)出现反复持续性室性心律失常,其中19例患者的病情无法通过药物治疗稳定。28例患者仅接受药物治疗。24例存活并出院。25例患者因并存心力衰竭或心绞痛,在紧急情况下(16例患者)或择期接受了梗死切除术或动脉瘤切除术(9例患者)。对这些患者尝试进行术中标测,但仅13例(52%)完全成功。手术死亡率为16%,所有死亡均发生在术前处于休克状态的患者中。21例接受手术治疗的幸存者中有5例需要长期抗心律失常治疗。24例接受药物治疗的患者中有21例在15±10个月的随访后仍存活且状况良好。21例接受手术治疗的患者中有19例在17.9±11个月后仍存活且状况良好。这些患者中有1例因严重二尖瓣反流需要再次手术。这些结果证实了心肌梗死后前2个月出现的持续性室性快速心律失常药物治疗预后较差,但表明联合药物和手术治疗方法可实现可接受的生存率。